# Why Gilead paid $1.68B but left the heavy lifting to Galapagos

- slug: why-gilead-paid-168b-but-left-the-heavy-lifting-to-galapagos
- date: 2026-03-24
- category: Biotech & Life Sciences

Gilead Sciences, the Foster City drugmaker best known for antivirals and now pushing deeper into inflammation, is paying a startling amount for Ouro Medicines, a young autoimmune biotech.

---